Kotang X.R. 500mg tablets, a diabetes drug prescribed in Taiwan, are being recalled for risk control purposes out of concern that the product may contain a carcinogenic ingredient, the nation's Food and Drug Administration (FDA) said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Premier-designate Cho picks labor, health, environment ministers (update)
04/19/2024 04:26 PM - Business
U.S. dollar closes sharply higher on Taipei forex market
04/19/2024 04:11 PM - Politics
Over NT$20 billion to be allocated to Hualien earthquake relief
04/19/2024 03:48 PM - Politics
Computer-aided Han Kuang war games to refer to recent conflicts
04/19/2024 03:23 PM - Business
Taiwan shares close down 3.81%
04/19/2024 02:02 PM